Clinical research published in Biochemical Pharmacology demonstrates that 5 amino 1mq treatment significantly reduces NNMT activity in adipocytes, leading to increased intracellular NAD+ concentrations
Troy Vitamin B12 Injection Actions For anaemias resulting from Vitamin B12 deficiencies in horses, cattle, dogs and cats
Where Does 5-Amino-1MQ Fit Into Current Research
Seek medical advice if you are taking B12 supplements and experience: Persistent skin changes, particularly acne-like eruptions or rosacea worsening Unexplained headaches or dizziness that coincide with supplement use Gastrointestinal symptoms including nausea or abdominal discomfort Any allergic reactions such as rash or itching Call 999 or go to A&E immediately if you experience: Difficulty breathing Swelling of the face, lips, tongue or throat Severe rash or itching Other symptoms of severe allergic reaction after taking B12 These symptoms warrant review of your supplementation regimen

Composition 5-amino-1MQ: 5 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Investigation of NNMT inhibition and its downstream metabolic effects Studies on NAD+ metabolism and energy homeostasis in preclinical models Development of analytical methods for small-molecule quantitation Stability and solubility assessment of 5-amino-1MQ under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
(1994) Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance